Bioray Biotech Co., Ltd(TW:7561)
NT$15.900.00 (0.00%)
TW:7561
Bioray Biotech Co., Ltd financials statements
NT$15.90
At close:0.00 (0.00%)
Bioray Biotech Co., Ltd (7561) Financial Statements
Bioray Biotech Co., Ltd Financial Overview
Bioray Biotech Co., Ltd's market cap is currently NT$478.36M. The company's EPS TTM is NT$0.65; its P/E ratio is 24.46; and it has a dividend yield of 5.97%. Bioray Biotech Co., Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 222.72M | NT$ 201.71M | NT$ 191.83M | NT$ 190.60M | NT$ 148.02M |
| Gross Profit | NT$ 90.57M | NT$ 79.03M | NT$ 77.65M | NT$ 80.51M | NT$ 67.29M |
| Operating Income | NT$ 37.90M | NT$ -4.32M | NT$ -19.33M | NT$ -235.00K | NT$ -8.11M |
| EBITDA | NT$ 61.49M | NT$ 27.69M | NT$ 12.13M | NT$ 24.27M | NT$ 13.86M |
| Net Income | NT$ 32.25M | NT$ 1.00M | NT$ -11.56M | NT$ 500.00K | NT$ -7.19M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 204.92M | NT$ 178.21M | NT$ 97.02M | NT$ 139.06M | NT$ 126.31M |
| Total Assets | NT$ 536.58M | NT$ 543.63M | NT$ 542.65M | NT$ 598.63M | NT$ 466.18M |
| Total Debt | NT$ 46.29M | NT$ 85.78M | NT$ 69.79M | NT$ 100.92M | NT$ 53.47M |
| Net Debt | NT$ -158.63M | NT$ -92.43M | NT$ -27.23M | NT$ -38.15M | NT$ -72.84M |
| Total Liabilities | NT$ 83.57M | NT$ 122.90M | NT$ 108.75M | NT$ 147.16M | NT$ 102.25M |
| Stockholders' Equity | NT$ 453.01M | NT$ 420.73M | NT$ 433.90M | NT$ 451.47M | NT$ 363.92M |
| Cash Flow | |||||
| Free Cash Flow | NT$ 71.36M | NT$ 13.35M | NT$ -10.95M | NT$ -57.90M | NT$ -6.71M |
| Operating Cash Flow | NT$ 71.73M | NT$ 16.65M | NT$ -762.00K | NT$ 2.48M | NT$ 8.83M |
| Investing Cash Flow | NT$ 727.00K | NT$ 53.72M | NT$ -12.55M | NT$ -59.63M | NT$ -19.79M |
| Financing Cash Flow | NT$ -45.75M | NT$ 10.82M | NT$ -28.73M | NT$ 69.92M | NT$ -8.64M |
Currency in TWD

